Martin Taarnhoj

Martin Taarnhøj is a Senior Advisor and an accomplished commercial leader with over 15 years of experience in the pharmaceutical industry. Throughout his tenure at AstraZeneca, Martin held several high-stakes leadership roles in sales and marketing, overseeing high-value portfolios across six distinct therapeutic areas.

A specialist in strategy development and in-market execution, Martin has led cross-functional commercial teams globally, with a focus on Western Europe and the Nordic-Baltic regions. He successfully served as the Head of Respiratory, Inflammation, and Autoimmunity, managing a business unit with over $350 million in annual revenue.

Since 2015, Martin has been a key driver in the global strategy and implementation of major Respiratory and COPD franchises. His professional philosophy of “leadership by example” and his track record of scaling commercial operations in competitive markets provide HealthTech180 with critical insight into pharmaceutical lifecycle management and global market expansion.